Issue 4/2018
Content (8 Articles)
Pharmacogenetics of Opioid Use Disorder Treatment
Richard C. Crist, Toni-Kim Clarke, Wade H. Berrettini
Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review
Antonios Douros, Matthew Ades, Christel Renoux
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review
Per Damkier, Poul Videbech
Effect of Statin Intensity on the Risk of Epilepsy After Ischaemic Stroke: Real-World Evidence from Population-Based Health Claims
Fang-Ju Lin, Hung-Wei Lin, Yunn-Fang Ho
Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study
Alison S. Poulton, Bruce Armstrong, Ralph K. Nanan
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer, Daniel D. Truong, Susan R. Criswell, Sotirios Parashos, Larissa Felt, Reed Johnson, Rajiv Patni
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer, Daniel D. Truong, Susan R. Criswell, Sotirios Parashos, Larissa Felt, Reed Johnson, Rajiv Patni